International Year of Health and Care Workers 2021
PH Important DayPublic HealthPublic Health Events

International Year of Health and Care Workers 2021

by Public Health Update
written by Public Health Update
Screen Shot 2021 02 07 at 18.55.38

The 73rd World Health Assembly, through its decision to strengthen Code implementation and to designate 2021 as the YHCWs reflects a collective vision on the health and care workforce. During the 73rd World Health Assembly, Member States spoke to the critical role of health and care workers in ensuring individuals’ and communities’ health and well-being. Member States emphasized that the COVID-19 pandemic has illustrated why all health and care workers are critical to health emergency responses and for health system preparedness and resilience.

Investing in health and care workers – their education, well-being and fair remuneration

Health employment acts as a boost to the economy and a multiplier of economic growth, which means that investing in the health and care workforce benefits the whole of society. The International Year of Health and Care Workers 2021 is an opportunity to draw attention to the need for greater investments in health and care workforce readiness, education and learning to manage the pandemic and its consequences and to roll out the COVID-19 vaccine.

Investments in education, continuing professional development, well-being and occupational safety in all of these areas are important preconditions for retaining and attracting health and care professionals. Without making health and care work a desirable and supported career path, countries will struggle to attract newcomers, including in rural areas, or to progress towards universal health coverage and stronger, more resilient health systems.

Health and care workers deserve concrete action

Beyond offering praise and applause, the YHCW aims to energize countries to collaboratively tackle persistent health and care worker challenges.

The health and well-being of the health and care workforce have always been important, but are now even more vital. As societies grapple with the consequences of prolonged stress and pressure on health and care workers, it is important that Member States take concrete steps to address their needs.

Throughout the year, stakeholders are requested to show appreciation to the workforce dedicated to the health and care of others, and to advocate for concerted efforts to:

  • improve their working conditions
  • invest in their education
  • expand their roles
  • protect their health and well-being.

Source of info (Official Link)

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

1 comment
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
The CIH-LMU Symposium on Global Health Perspectives: Climate Change and Migration
Global Health NewsEnvironmental Health & Climate ChangePublic Health EventsSymposium

The CIH-LMU Symposium on Global Health Perspectives: Climate Change and Migration

by Public Health Update
written by Public Health Update

The CIHLMU Symposium on Global Health Perspectives: Climate Change and Migration will be held on Friday, March 12, 2021.

The effects of climate change cannot be emphasized enough. Climate change is not only affecting global health issues but also has an impact worldwide on economies. Therefore, changes to our environment are likely to become increasingly important causal factors of migration globally in years ahead. One of the key challenges will be to improve understanding of how environmental migration relates to vulnerability of people, as every person on the planet is a potential stakeholder in the essentials of interactions between the climate, environment and the health of human beings.

Aim

The aim with this symposium is to highlight knowledge to reduce vulnerabilities and enhance the resilience of communities and ecosystems affected by climate change. By creating awareness about the severity of consequences from climate change, we would like to address these issues especially related to global health and migration. This augments the scientific understanding of climate change and attendees will be equipped with relevant mitigating strategies to help populations adapt to these associated vulnerabilities.

Mode of Delivery

This symposium will be held online via Zoom, with presentations by respected and prominent speakers followed by a panel discussion.

Target Group

The organizers of the symposium would like to extend an invitation for all of those who are interested. Kindly have a look at the symposium’s agenda and the symposium’s flyer to learn more about the organisation of the day and the different lectures and speakers.

Event date: Friday, 12th March 2021, 09:00-16:00 (CET)

Language: English

Registration

Registration and participation is free of charge. If you want to register, please send an email with the following information:

  • Your name
  • Your nationality
  • Your profession and institution

Alternatively, you can fill in the Registration form and send it to CIH.Symposium.2021@lrz.uni-muenchen.de

If you need more information, please do not hesitate to organizer.

Registration form
Official Announcement

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
WHO announces updated critical concentrations for susceptibility testing for rifampicin
Public Health UpdateCommunicable DiseasesGlobal Health NewsInternational Plan, Policy & Guidelines

WHO announces updated critical concentrations for susceptibility testing for rifampicin

by Public Health Update
written by Public Health Update

5 February 2021 | GENEVA – The critical concentrations for culture-based phenotypic drug susceptibility testing (DST) to first-line anti-TB drugs have been revised by the the World Health Organization (WHO). Critical concentrations for rifampicin have been lowered while those for isoniazid have been maintained at the present level. This update helps address the discordance observed between phenotypic and molecular methods to detect rifampicin resistance and improves the accuracy of DST. As a result patients with TB will have a more accurate  diagnosis.

The revision was the outcome of a Technical Expert Group meeting convened by WHO in 2020 to assess the results of a systematic review of published literature on critical concentrations for DST of the most important first-line anti-TB drugs, isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). New evidence showed that critical concentrations used for phenotypic methods to detect rifampicin resistance may incorrectly classify strains with certain mutations. The following media were considered: Löwenstein-Jensen (LJ), Middlebrook 7H10 (7H10), Middlebrook 7H11 (7H11) and BACTEC™ Mycobacterial Growth Indicator Tube™ 960 (MGIT).Technical Report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine)

Guidance has been provided to resolve discordance between genotypic and phenotypic results for these drugs and areas for further research have been highlighted. The full report is available here.

DST methods continue to have a very important role to identify resistance not detected by molecular assays and to support the interpretation of molecular assays results. However, they require sophisticated laboratory infrastructure, qualified staff and strict quality assurance procedures.

Download Full Document
PDF

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Australia Awards Scholarships
Public HealthFellowships, Studentship & ScholarshipsGrants and Funding OpportunitiesMaster's DegreeSchool of Public Health

Australia Awards Scholarships 2022

by Public Health Update
written by Public Health Update

Australia Awards Scholarships are long-term development awards funded by the Australian Government’s Department of Foreign Affairs and Trade. The study and research opportunities provided through Australia Awards Scholarships develop the skills and knowledge of individuals to drive change and contribute to development.

Who can apply

Australia Awards Scholarship applications are accepted from individuals who are citizens of participating countries and meet eligibility criteria specific to their country. In South Asia, Australia Awards Scholarships are open to suitably qualified nationals of Bangladesh, Bhutan, the Maldives, Nepal, Pakistan and Sri Lanka. Women, people with disability and individuals from traditionally marginalised groups are encouraged to apply.

Opportunity

An Australia Awards Scholarship provides you with the opportunity to gain an internationally recognised qualification from an Australian institution. It includes all the necessary support and funding to complete your study.

Your career will benefit from new knowledge, leadership skills and the links you create both in Australia and through the Australia Global Alumni network. On your return home, you can make a vital contribution to the social and economic development of Nepal.

The application process is transparent and competitive, providing equal opportunity to all eligible applicants, regardless of gender, ethnicity or disability.

Applications for Australia Awards Scholarships commencing in 2022 are now open and will close 30 April 2021.

Australia Awards Scholarships for Nepal will be offered to undertake Master’s degree study programs in the priority development sectors of Economic Development, Education, Health, Governance, Gender Equality, Disability and Social Inclusion, and Water Resource Management.

Level of study

Australia Awards Scholarships provide citizens of Nepal with the opportunity to obtain a qualification at an Australian tertiary institution. Scholarships will be offered for master’s degree programs (by coursework or research) for study commencing in 2022.

English language requirements

To be eligible for an Australia Awards Scholarship, you must meet certain standards in English language proficiency, with the results valid as at 1 January 2022. At minimum, you must have:

  • an IELTS (Academic) overall score of at least 6.5 with no band less than 6.0; or
  • a TOEFL internet based (iBT) score of at least 84, with a minimum of 21 in all sub-tests; or
  • a PTE (Academic) overall score of 58 with no communicative skill score less than 50.

Women, people with disability, members of traditionally marginalised groups and nominated public servants will be considered for eligibility with an IELTS (Academic) overall score of 6.0 or above (with no individual band less than 5.5) or an equivalent TOEFL (iBT) or PTE (Academic) test score. However, if offered an Australia Awards Scholarship, these applicants must meet the English language requirements of their course.

Australia Awards benefits
Australia Awards Scholarships are offered for the minimum period necessary for the individual to complete the academic program specified by the Australian education institution, including any preparatory training.

Scholarship recipients will receive the following entitlements:
• return air travel
• a one-off establishment allowance on arrival
• full tuition fees
• contribution to living expenses
• introductory academic program
• overseas student health cover for the duration of the Scholarship
• supplementary academic support
• fieldwork allowance for research students and those undertaking a master’s degree by coursework that has a compulsory fieldwork component.

Qualifications and work experience

To be eligible, applicants must have the following qualifications and work experience:

  • a four-year bachelor’s degree with a minimum of three years’ relevant full-time work experience earned after the bachelor’s degree; or
  • a three-year bachelor’s degree with at least a oneyear master’s degree with a minimum of three years’ relevant full-time work experience earned after the bachelor’s degree; or
  • a two-year bachelor’s degree with at least a two-year master’s degree with a minimum of three years’ relevant full time work experience earned after the bachelor’s degree. Scholarships will not be available for courses of study in Australia where the applicant has already achieved a qualification that is deemed to be equivalent to the Australian qualification.

Australia Awards applicants must meet all eligibility requirements, including citizenship and residency requirements, detailed in the Australia Awards Scholarships Policy Handbook, available at:
www.dfat.gov.au/about-us/publications/Pages/australiaawards-scholarships-policy-handbook.

For further information, contact the Australia Awards office in Nepal:
+977 1 4002614
inquiries@australiaawardsnepal.org

Applications for Australia Awards Scholarships now close on 31 May 2021. 

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
World Cancer Day
PH Important DayNon- Communicable Diseases (NCDs)Public HealthPublic Health EventsPublic Health Update

World Cancer Day 2021: I Am And I Will

by Public Health Update
written by Public Health Update

World Cancer Day 2021: I Am And I Will! Together, all of our actions matter.

World Cancer Day, every 4 February is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education and catalysing personal, collective and government action, we’re working together to reimagine a world where millions of preventable cancer deaths are saved and access to life-saving cancer treatment and care is equal for all – no matter who you are or where you live. Because, we believe that cancer isn’t just a health issue but a human issue that touches all of us.

World Cancer Day aims to save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease.

Why cancer?

  • Cancer is a critical health and human issue.
  • Today, 9.6 million people each year will die from cancer. Making it the second-most deadly disease.
  • 70%of cancer deaths occur in low-to-middle income countries.
  • The total annual economic cost of cancer is estimated at approximately US$1.16 trillion.
  • At least one third of common cancers are preventable.
  • Less than 30%of low-income countries have cancer treatment services available (compared to 90% in high-income countries).
  • Up to 3.7 million lives could be saved each year through resource appropriate strategies for prevention, early detection and timely and quality treatment.

Campaign theme:I Am and I Will

2021 – the ultimate year of the ‘I Am and I Will’ campaign – shows us that our actions have an impact on everyone around us, within our neighbourhood, communities and cities. And that more than ever, our actions are also being felt across borders and oceans. This year is a reminder of the enduring power of cooperation and collective action. When we choose to come together, we can achieve what we all wish for: a healthier, brighter world without cancer.

Related

#WorldCancerDay#IAmAndIWill #cancer

More info: Official website

1 comment
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Universitas Gadjah Mada, Indonesia
Fellowships, Studentship & ScholarshipsGrants and Funding OpportunitiesImplementation ResearchMaster's DegreePublic Health OpportunitiesPublic Health OpportunitySchool of Public Health

Call for applications! TDR Postgraduate Scholarship in Implementation Research- Universitas Gadjah Mada

by Public Health Update
written by Public Health Update

Call for applications! TDR Postgraduate Scholarship in Implementation Research Academic Year 2021/2022

Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada (UGM) of Yogyakarta, Indonesia, invites suitably qualified candidates to apply for a place in the following full-time postgraduate programme, with a focus on Implementation Research for the 2021-2022 academic year.
Funding for these full scholarshipsis from TDR, the Special Programme for Research and Training in Tropical Diseases, based at the World Health Organization in Geneva (TDR Postgraduate training support). Only applicants from low- and middle-income countries of WHO South-East Asia and Western Pacific Regions are eligible.
The training will be focused on courses relevant to a career in implementation research on infectious diseases of poverty, including neglected tropical diseases, malaria, TB/HIV and COVID-19. Implementation research is a growing field that supports the identification of health system bottlenecks and approaches to address them, and is particularly useful in low- and middle- income countries where many health interventions do not reach those who need them the most. The goal of this scheme is to enhance postgraduate training capacity and boost the number of researchers in low- and middle-income countries.
Further information on implementation research is available from: IR training and IR toolkit A limited number of scholarships will be offered for the 2021/2022 academic year in the International Master Programme in Public Health, leading to an MPH degree (2 years duration). The programme is taught in English.

Recipients will be enrolled as postgraduate students, and their careers will be tracked through the TDR postgraduate alumni platform, IR Connect, which monitors the impact of the programme and provides networking and opportunities to increase visibility for students and alumni.

ELIGIBILITY FOR SCHOLARSHIP

Applicants should:

  • Be nationals of, and residents in, low- and middle income countries (as defined by the World Bank) of WHO South-East Asia region and West Pacific region.
  • Be under 35 years old for the Master programme.
  • Meet the University requirements for international postgraduate students
  • Meet the academic requirements:
    – A bachelor’s degree with a cumulative Grade Point Average of at least 3.00 out of 4 AcEPT score of at least 268 or TOEFL score of at least 550 or IELTS score of at least 5.5
    – Desk evaluation on undergraduate academic documents
  • Consent to meet health requirements in line with regulations of the Indonesian government and UGM.

THE SCHOLARSHIP PACKAGE

The scholarship covers:

  • Return economy airfare between the home country of the student and Yogyakarta, Indonesia;
  • Tuition fees and a basic medical and accident insurance;
  • Support for research project/thesis expenses, including travel and sustenance during data collection in home country;
  • Indonesian language course to improve integration in the university’s environment; and
  • Monthly stipend to cover living expenses equivalent to local living cost.
APPLYING FOR THE TDR POSTGRADUATE SCHOLARSHIP SCHEME AT UGM

To apply for a TDR Postgraduate Scholarship, you must complete the following two steps:
Step 1. Apply for Master Programme
a. International applicants: please log in or sign up at https://admission.ugm.ac.id/ and choose “TDR Postgraduate Scholarship in Implementation Research” for Master Programme. Please send the online form and all documents with good quality to graduate.fk@ugm.ac.id
b. Indonesian applicants: please send the application form and requirements mentioned in um.ugm.ac.id to graduate.fk@ugm.ac.id. Please write a motivation letter and scholarship application form in English.
Step 2. Complete the TDR postgraduate scholarship application form (attached) and email this form to: graduate.fk@ugm.ac.id.
Only completed forms will be further processed.

CALENDAR FOR APPLICATION

Application open: 1 February 2021
Deadline for application: 26 March 2021
Announcement of selection result: 3 May 2021
Selected applicants will receive a letter of offer from the University and have 3 calendar days to confirm acceptance after the notification. Faculty of Medicine, Public Health and Nursing, UGM reserves the right to refuse or end attribution of the scholarship if the provided information has been proven false.
Application deadline: 26 March 2021 (Extended deadline for application April 16, 2021)

MORE INFORMATION
For more information on the scheme at Faculty of Medicine, Public Health and Nursing, UGM, please contact:
Ms Yuyun Yohana
The Graduate Programme Office, Faculty of Medicine, Public Health and Nursing, UGM
Tel no : (+62-274) 560300 ext. 205
Fax no : (+62-274) 581876
E-mail : graduate.fk@ugm.ac.id
Website: http://graduate.fk.ugm.ac.id/

OFFICIAL NOTICE
WHO TDR

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
February: National Iodine Month
Public HealthPH Important DayPublic Health EventsPublic Health NewsPublic Health ProgramsPublic Health Update

February : National Iodine Awareness Month

by Public Health Update
written by Public Health Update

Iodine Month

National Iodine Month has been celebrated in February each year to raise awareness on the use of two child-logo salt for optimum iodine intake to combat iodine deficiency disorders in Nepal.

Screen Shot 2021 01 31 at 19.57.32
February: National Iodine Month

The MoHP adopted a policy to fortify all edible salt in 1973 to address iodine deficiency disorders (IDD) through universal salt iodization. The Salt Trading Corporation is responsible for the iodine fortification of all edible salt and its distribution, while MoHP is responsible for promoting iodized salt and its marketing to increase consumption.

The government uses the Two-Child Logo to certify adequately iodized salt and DoHS has been implementing a social marketing campaign of this salt to improve awareness of its use in households.

National surveys reports an increase in the number of households using adequately iodized salt from 55 percent in 1998 to 95 percent in 2016. However, there is disparities in the use of iodized salt. The NDHS 2016 found the Province 2 to have the highest coverage (99.3 percent), while the Province 6 had the lowest (85.1 percent).

Government’s strategies to control of iodine deficiency disorders

  • The universal iodization of salt.
  • Strengthen implementation of the Iodized Salt Act, 2055 to ensure that all edible salt is iodized.
  • The social marketing of certified two-child logo iodized salt.
  • Ensure the systematic monitoring of iodized salt.
  • Increase the accessibility and market share of iodized packet salt with the two-child logo.
  • Create awareness about the importance of using iodized salt to control iodine deficiency disorder (IDD) through social marketing campaign.
12 1
23

CHANGE YOUR PROFILE PICTURE

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

1 comment
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
World Leprosy Day 2021 #BeatLeprosy
PH Important DayNeglected Tropical Diseases (NTDs)Public Health EventsPublic Health Update

Messages for World Leprosy Day 2021

by Public Health Update
written by Public Health Update

Yohei Sasakawa, WHO Goodwill Ambassador for Leprosy Elimination

Over the past year, the headlines have been dominated by COVID-19. It is easy to overlook other diseases, especially a disease such as leprosy that many people think is a disease of the past.

But leprosy requires our attention. There are still some 200,000 new cases diagnosed worldwide each year. Millions of people are living with some form of disability as a result of leprosy.

Both the label “leprosy” and the disability that can result if this age-old disease goes untreated can lead to social exclusion. Persons affected by leprosy continue to face discrimination, reinforced in some countries by outdated laws that make leprosy grounds for divorce, prevent people with the disease from participating in public life or place other restrictions on their activities.

As WHO Goodwill Ambassador for Leprosy Elimination, I have seen for myself how leprosy has marginalized individuals. Women and children are particularly vulnerable to the social and economic consequences of the disease.

Overcoming leprosy involves more than early diagnosis and prompt treatment. It also requires changing mindsets so that leprosy is no longer a source of shame or prejudice. We must remove all barriers in the way of those seeking medical care. We must eliminate the obstacles that prevent affected individuals and their families from living in dignity and enjoying all their basic human rights as full members of society.

I often talk about leprosy in terms of a motorcycle. The front wheel represents curing the disease and the rear wheel symbolizes ending discrimination. Only when both wheels are turning at the same time will we make progress toward our destination of a leprosy-free world.

As I survey the road ahead, I am confident we are moving in the right direction: the WHO’s Global Leprosy Strategy for 2021-2030 will generate renewed momentum; organizations of persons affected by leprosy are becoming more influential, and their calls for change more powerful; and the UN Special Rapporteur on leprosy is working tirelessly to see that principles and guidelines on the elimination of discrimination against persons affected by leprosy and their family members are fully implemented.

I believe we will achieve a world without leprosy one day. But along the way, we need to realize an inclusive society in which everyone has access to quality treatment and services, and a diagnosis of leprosy no longer comes with a possibility of devastating physical, social, economic or psychological consequences.

Compared to other diseases, leprosy may only affect a small number of people, but we are all responsible for building an inclusive world.

Official link
WHO

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
WHO announces updated definitions of extensively drug-resistant tuberculosis
ActivitiesCommunicable DiseasesGlobal Health NewsPublic Health NewsPublic Health Update

WHO announces updated definitions of extensively drug-resistant tuberculosis

by Public Health Update
written by Public Health Update

27 January 2021 | GENEVA – The definition of extensively drug-resistant tuberculosis (XDR-TB) has been revised by the World Health Organization (WHO)’s Global TB Programme, who have also defined pre-XDR-TB for the first time, highlighting the seriousness of these forms of TB. New definitions for pre-XDR and XDR-TB will help to define more precisely groups of TB patients who require complex treatment regimens. These new definitions are also expected to lead to better reporting, surveillance and monitoring of drug-resistant TB in countries. They may also stimulate the development of better treatment regimens for these dangerous forms of TB disease.

“Drug resistant TB is a serious clinical condition and remains a global public health concern. The new definitions will enable access to more effective treatment options for patients with drug resistant TB. We hope that they will also stimulate further capacity building in national laboratories and future research on rapid drug susceptibility testing for new and repurposed TB medicines,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme.  “We urge national TB programmes to transition to these new definitions.”

The new definition of pre-XDR-TB is: TB caused by Mycobacterium tuberculosis (M. tuberculosis) strains that fulfil the definition of multidrug resistant and rifampicin-resistant TB (MDR/RR-TB) and which are also resistant to any fluoroquinolone. The definition of MDR-TB* remains unchanged.
 
The updated definition of XDR-TB is: TB caused by Mycobacterium tuberculosis (M. tuberculosis) strains that fulfil the definition of MDR/RR-TB and which are also resistant to any fluoroquinolone and at least one additional Group A drug (Group A drugs are the most potent group of drugs in the ranking of second-line medicines for the treatment of drug-resistant forms of TB using longer treatment regimens and comprise levofloxacin, moxifloxacin, bedaquiline and linezolid).
 
The two definitions of pre-XDR-TB and XDR-TB point to increasing progression of the severity of the disease, due to resistance to additional medicines. Subsequently, a more limited number of medicines are at a clinician’s disposal to effectively treat it.
 
The new definitions of pre-XDR and XDR-TB apply from January 2021. National TB programmes will need to orient their staff, laboratory and surveillance systems to accommodate the new definitions. The changes required for the definition of XDR-TB require scale up of rapid molecular tests to detect fluoroquinolone-resistance as well as laboratory capacity to perform DST for bedaquiline and linezolid.
 
The definitions were updated in October 2020 following a consultation convened by WHO’s Global TB Programme that brought together over 70 participants, representing countries, bilateral and multilateral agencies, international organizations, nongovernmental organizations, civil society and academia.
 
About 470,000 people fall ill with MDR/RR-TB and about 180,000 die from this form of TB each year, according to WHO estimates. Globally, in 105 countries with representative data, 20% of the people with MDR/RR-TB  also have resistance to another potent drug for the treatment of drug-resistant TB – a fluoroquinolone. Extensively drug resistant TB is a more serious form of MDR-TB, with poorer treatment outcomes reported for those affected by this condition.
 
* MDR-TB: Resistance of Mycobacterium tuberculosis strains to at least isoniazid and rifampicin, the cornerstone medicines for the treatment of TB. Rifampicin-resistant disease on its own requires similar clinical management as MDR-TB.

The World Health Organization (WHO) consultation meeting on the definition of extensively drug resistant (XDR) tuberculosis (TB) was held on 27, 28 and 29 October 2020 as an online meeting, organized by the Global TB Programme, WHO, Geneva, Switzerland. Over 70 participants attended the meeting, representing countries, bilateral and multilateral agencies, international organizations, nongovernmental organizations, civil society and academia.

Read More
Official LINK

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

2 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
COVID-19 Vaccine FAQs
Outbreak NewsActivitiesNoticePublic Health EventsPublic Health Programs

COVID-19 Vaccine FAQs (Nepali)

by Public Health Update
written by Public Health Update

The Ministry of Health & Population has released Frequently Asked Questions (FAQs) on the COVID-19 vaccine. The COVID-19 vaccination campaign will be launched from Jan 27, 2021 in Nepal.

Download PDF FILE
MOHP WEBSITE
COVID-19 Vaccine FAQs (Nepali)
COVID-19 Vaccine FAQs (Nepali)
Download PDF FILE
MOHP WEBSITE

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

2 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Newer Posts
Older Posts
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023